Product Information
MK-8353 is a novel, potent and selective inhibitor of the mek1/2 enzyme. It is active in vitro against a variety of human cancer cell lines, including metastatic colorectal cancer cells that are resistant to other tyrosine kinase inhibitors. MK-8353 has been found to inhibit tumor growth in vivo by inhibiting the phosphorylation of mek1/2 and its downstream signaling pathways. The compound also inhibited mutant melanoma growth in vivo and suppressed the proliferation of cervical cancer cells in vitro. MK-8353 is currently being evaluated for use as a potential anticancer drug candidate.
Chemical properties
Technical inquiry about: 3D-JXB17373 MK-8353 (SCH900353)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
